Statements (24)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:CEO |
gptkb:Emil_D._Kakkis
|
gptkbp:country |
gptkb:United_States
|
gptkbp:focusesOn |
rare diseases
|
gptkbp:foundedBy |
gptkb:Emil_D._Kakkis
|
gptkbp:foundedYear |
2010
|
gptkbp:headquartersLocation |
gptkb:Novato,_California,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Ultragenyx
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:notableProduct |
gptkb:Crysvita
gptkb:Mepsevii |
gptkbp:numberOfEmployees |
over 1000
|
gptkbp:product |
gptkb:Crysvita
gptkb:Dojolvi gptkb:Evkeeza gptkb:Mepsevii |
gptkbp:specializesIn |
development of novel products for rare and ultra-rare diseases
|
gptkbp:stockExchange |
gptkb:NASDAQ
|
gptkbp:stockSymbol |
RARE
|
gptkbp:tradedOn |
gptkb:NASDAQ:_RARE
|
gptkbp:website |
https://www.ultragenyx.com/
|
gptkbp:bfsParent |
gptkb:F-Prime_Capital
gptkb:F-Prime_Capital_Partners |
gptkbp:bfsLayer |
6
|